New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3

PURPOSE: The aim of this study was to explore a new model of clinical decision-making to predict the occurrence of clinically significant prostate cancer (csPCa). PATIENTS AND METHODS: The demographic and clinical characteristics of 152 patients were recorded. Prostate-specific antigen (PSA), PSA de...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chen, Qiu, Feng, Jin, Di, Wei, Xuedong, Chen, Zongxin, Wang, Ximing, Zhao, Xiaojun, Guo, Linchuan, Pu, Jinxian, Hou, Jianquan, Huang, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289138/
https://www.ncbi.nlm.nih.gov/pubmed/35860546
http://dx.doi.org/10.3389/fonc.2022.908956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289138/
https://www.ncbi.nlm.nih.gov/pubmed/35860546
http://dx.doi.org/10.3389/fonc.2022.908956

Ejemplares similares